Urology resident-in-training | MD PhD | Research fellow in Functional Urology | Maastricht UMC+, the Netherlands | ICS wiki committee | Views are my own.
Validation studies particularly valuable to convince the sceptics who point to sampling variance, bladder volume control, patient and observer variability and confounders (like UTIs) as likely affecting bladder wall thickness
I think that was a pretty easy choice for the ICS. With Paul Abrams, Alison Brading and Karl-Erik Andersson it was Chris who inspired me into functional urology and its basic science
@drdanwood@urohash Great fun debate with my friend @urohash thank you @SIU_urology Summary is Mdm discussion. Discuss with pt all options. Counsel them about all. Pt decides. If you don’t have access to sns / ptns refer on !
In patients with UTIs caused by MDR microorganisms
who have limited or no oral Rx options -
intravesical gentamicin instillation
is a valuable treatment option
https://t.co/7k67PZszr9
@janneke_st
Not performing a systematic transrectal biopsy
when the pre-biopsy MRI was negative
would have led to under-detection
of approximately 1 in 6
significant #prostatecancer case
https://t.co/Lu8vIKPACU
#pcsm#urosome
@PSUrol
More than half of men with prostate cancer are not offered therapy for sexual dysfunction. Are you offering sexual and fertility care to your uro-oncology patients? Learn more at the @Uroweb#eau19 plenary on andrology monday 18/3 https://t.co/MSPl5WvAfr @essm_tweets@JSnksen
Slings or artificial sphincter for post-prostatectomy incontinence? Sphincters probably more effective but don’t forget complications and revisions! #EAU19
Our results suggest that micropapillary urothelial bladder cancer does not necessarily mandate different treatment algorithms. Nevertheless, each case should be discussed individually considering other clinicopathological factors. https://t.co/3bPiFpOiHS